Higher Rate of FDA New Drug Approvals a Major Factor in Biotech Industry's Success in 2012

The iShares Nasdaq Biotechnology Index Fund and the SPDR S&P Biotech ETF have both gained over 25 percent year-to-date. Five Star Equities examines the outlook for companies in the Biotech Industry and provides equity research on Athersys, Inc.

http://www.sys-con.com/node/2477383